Earnings FlashRVTY
Revvity, Inc. (RVTY) rises on earnings beats
Revvity, Inc. (RVTY) rises 7.0% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook signals.
May 5, 20262 MIN
TickerSpark Feed
healthcare
Everything tagged "healthcare" across research, earnings, and macro.
70 articles
Research ReportWAT
Waters Corporation (WAT): Quality Growth Meets Integration Risk
Waters posted solid 2025 growth and enters 2026 with momentum, but the BD Biosciences & Diagnostic Solutions deal adds integration risk and a richer valuation. The stock looks like a Hold leaning to Buy on weakness as synergies and recurring revenue expansion offset execution concerns.
May 5, 202625 MIN
Earnings AnalysisTWST
Twist Bioscience Corporation (TWST) drops after deep earnings miss
Twist Bioscience Corporation (TWST) drops despite revenue growth and raised guidance, as a wider-than-expected EPS loss overshadowed strong segment momentum, margin improvement, and continued sequential sales gains. This deep-dive breaks down the earnings miss, operating trends, and why investors focused on profitability over the top-line beat.
May 5, 202610 MIN
Research ReportAXSM
Axsome Therapeutics (AXSM): AUVELITY Drives a Premium Growth Story
Axsome has evolved into a commercial CNS growth story, led by AUVELITY’s rapid prescription gains and a newly expanded Alzheimer’s agitation opportunity. The stock looks attractive on execution, but valuation and ongoing losses keep it from being a low-risk idea.
May 4, 202621 MIN
Research ReportSNY
Sanofi (SNY): Dupixent Drives a Buy Case
Sanofi is becoming a more focused biopharma compounder, led by Dupixent growth, vaccine strength, and expanding launch sales. The stock looks inexpensive versus its cash generation and earnings power.
May 4, 202620 MIN
Research ReportTWST
Twist Bioscience (TWST): Margin Gains, But Valuation Is Rich
Twist Bioscience is scaling revenue, expanding gross margin, and gaining traction in AI-enabled discovery, but the stock already prices in much of the progress. Our view is Hold as the company works toward profitability.
May 4, 202622 MIN
Earnings FlashTWST
Twist Bioscience Corporation (TWST) drops on earnings misses
Twist Bioscience Corporation (TWST) drops 5.5% after reporting earnings misses, as investors react to weaker-than-expected results and reassess the stock's near-term outlook.
May 4, 20262 MIN
Research ReportSYK
Stryker (SYK): Premium Medtech Growth, Rich Valuation
Stryker is executing well with double-digit revenue growth, strong segment momentum, and raised 2026 EPS guidance. The stock remains a Buy, but the premium valuation argues for patience on pullbacks.
May 1, 202629 MIN
Research ReportAMGN
Amgen (AMGN): Growth Broadens Beyond Patent Cliffs
Amgen is growing through patent expirations with broad-based momentum across Repatha, rare disease, oncology, and biosimilars. The stock looks like a Buy, though valuation already reflects much of the resilience.
May 1, 202621 MIN
Research ReportLLY
Eli Lilly (LLY): Incretin Growth Still Drives the Story
Eli Lilly is delivering exceptional revenue and EPS growth, led by Mounjaro and Zepbound, while raising 2026 guidance again. The stock is expensive, but the franchise momentum and pipeline breadth keep the long-term case intact.
Apr 30, 202627 MIN
Earnings AnalysisALGN
Align Technology, Inc. (ALGN) Gains on Deep Earnings Analysis
Align Technology, Inc. (ALGN) missed EPS but still gained as investors looked past the headline miss to record clear aligner shipments, steady international growth, and reaffirmed 2026 guidance. This deep-dive examines the revenue mix, margin pressure, buybacks, and why the market stayed constructive.
Apr 30, 20269 MIN
Research ReportALGN
Align Technology (ALGN): Clear Aligner Growth With Net Cash
Align Technology remains a category leader in clear aligners with a growing digital dentistry platform and a fortress-like balance sheet. The stock looks attractive as a medium-term compounder, though pricing pressure keeps the growth story from being a pure momentum trade.
Apr 29, 202621 MIN
On-Demand Research
Need research on a stock not covered here?
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator